Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

DVT/VTE

  • 1
    News

    Controversy surrounds calf vein thrombosis treatment

    January 30, 2018

    CHICAGO – Anticoagulation, filter, or surveillance? Large retrospective study provides answers.

  • 1
    News

    Acute kidney injury linked with doubled inpatient VTEs

    December 8, 2017

    TORONTO – Which comes first: the acute kidney injury or the venous thromboembolism?

  • 1
    News

    Pharmacomechanical thrombolysis does not reduce post-thrombotic syndrome risk

    December 6, 2017

    The ATTRACT trial results contrast with recent reports from another randomized trial, known as CAVENT.

  • 1
    News

    Idarucizumab reversed dabigatran completely and rapidly in study

    July 11, 2017

    One drug reversed the anticoagulant effect of another completely and rapidly.

  • 1
    News

    VIDEO: Meta-analysis favors anticoagulation for patients with cirrhosis and portal vein thrombosis 

    July 5, 2017

    Anticoagulation has significant benefits and does not increase bleeding risk, regardless of the severity of liver failure.

  • 1
    News

    FDA approves betrixaban for VTE prophylaxis

    June 23, 2017

    An orally administered agent has been approved for VTE prophylaxis in at risk hospitalized patients.

  • 1
    News

    Low-dose aspirin bests dual-antiplatelet therapy in TAVR

    June 8, 2017

    PARIS – ARTE trial is hailed as practice changing.

Previous1 2
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences